DOV vs HBIO · P/E 27, rev $4.24B vs rev $22.7M
Dover Corporation (DOV) versus Harvard Bioscience Inc (HBIO) — a side-by-side from cached financials, not a winner call.
Dover Corporation (DOV) is a specialty industrial machinery company listed on US.
Harvard Bioscience Inc (HBIO) is a medical instruments & supplies company listed on US.
Latest reported DOV revenue for 2026-06-30 was $4.24B. Net income was $550.7M. DOV currently screens at market cap $28.92B and trailing P/E 26.8.
Latest reported HBIO revenue for 2026-06-30 was $22.7M. Net income was -$2.9M. Revenue was up 9.5% from 2026-03-31 to 2026-06-30. HBIO currently screens at market cap $20.3M.
DOV currently screens at market cap $28.92B and trailing P/E 26.8. HBIO currently screens at market cap $20.3M.
Not investment advice. Open the DOV and HBIO stock pages for the full models.
Not investment advice.